Eos Advisory

Eos Advisory is a venture capital firm based in St Andrews, Scotland, focusing on early-stage investments in science and technology companies that aim to address significant societal and environmental issues. Founded in 2014, the firm has deep roots in Scotland and a global perspective, serving as a trusted link between non-specialist investors and highly specialized investments. Eos Advisory manages an Innovation Fund (EIS) with an annual close in Q4, demonstrating its commitment to supporting innovative ventures.

The firm's investment strategy emphasizes sectors such as disease diagnosis, prevention and treatment; food and water security; energy security, climate change, and pollution; and the improvement and sustainability of industrial processes. Eos Advisory seeks to invest in companies whose addressable market is global, leveraging Scotland's global reputation for innovation and university research. The firm has a hands-on approach to supporting portfolio companies, working alongside co-investors to add value and accelerate growth.

Eos Advisory's portfolio includes companies like Laverock Therapeutics, DxCover, and Concinnity Genetics, reflecting its focus on transformative health technologies and sustainable solutions. The firm collaborates with family offices, individuals, companies, and institutional investors, offering opportunities for co-investment and participation in its Innovation Fund. Eos Advisory is committed to building a diverse and inclusive organization through its investments, investors, and team, and is among the first signatories to the Pathways Pledge, aiming to improve accessibility of investment and ensure a diverse selection panel.